51�Թ�

In 2017, my father was diagnosed with Stage IV myelofibrosis, a rare and deadly form of blood cancer.

During unrelated medical testing in 2020, doctors detected signs of myelofibrosis, a chronic leukemia characterized by a buildup of scar tissue in the bone marrow.

And since August 2019, when he was diagnosed with primary myelofibrosis, a rare bone marrow cancer, he has felt what he called a fundamental fear most vividly in the mornings.

Food and Drug Administration had approved its oral therapy to treat anemia in patients with a type of bone marrow cancer called myelofibrosis.

Food and Drug Administration has extended the review period for its experimental drug momelotinib, which is designed to treat anaemic patients with a type of bone marrow cancer called myelofibrosis.